- Home
- REFI vs TCMD Comparison
REFI vs TCMD Comparison
Compare REFI & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REFI | TCMD |
|---|---|---|
| Founded | 2021 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.6M | 300.1M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | REFI | TCMD |
|---|---|---|
| Price | $12.76 | $29.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $20.00 | ★ $23.25 |
| AVG Volume (30 Days) | 149.6K | ★ 334.7K |
| Earning Date | 11-04-2025 | 02-17-2026 |
| Dividend Yield | ★ 16.11% | N/A |
| EPS Growth | N/A | ★ 18.66 |
| EPS | ★ 1.69 | 0.77 |
| Revenue | $54,287,847.00 | ★ $311,513,000.00 |
| Revenue This Year | $13.78 | $11.31 |
| Revenue Next Year | $4.07 | $8.83 |
| P/E Ratio | ★ $7.55 | $38.18 |
| Revenue Growth | N/A | ★ 9.28 |
| 52 Week Low | $11.85 | $8.61 |
| 52 Week High | $16.27 | $30.24 |
Technical Indicators
Market Signals| Indicator | REFI | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 67.59 |
| Support Level | $12.76 | $29.02 |
| Resistance Level | $13.20 | $29.82 |
| Average True Range (ATR) | 0.28 | 0.89 |
| MACD | -0.02 | -0.24 |
| Stochastic Oscillator | 15.06 | 68.61 |
Price Performance
Historical ComparisonAbout REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.